CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells

BACKGROUND: Various nanocarriers have been used to deliver subunit vaccines specifically to dendritic cells (DCs) for the improvement of immunogenicity. However, due to their insufficient DC priming ability, these vaccines could not elicit effective innate immunity. We have recently developed a DC-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Hidenori, Somiya, Masaharu, Iijima, Masumi, Arakawa, Takeshi, Kuroda, Shun’ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076409/
https://www.ncbi.nlm.nih.gov/pubmed/30077180
http://dx.doi.org/10.1186/s12951-018-0386-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076409/
https://www.ncbi.nlm.nih.gov/pubmed/30077180
http://dx.doi.org/10.1186/s12951-018-0386-6

Ejemplares similares